Suraksha Diagnostic block deals, bulk deals, insider trading and stake changes
NSE: SURAKSHABSE: 544293Healthcare ServicesSmall Cap
Suraksha Diagnostic Limited · Face value ₹2 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Dec 2024 · Issue price ₹441
Last close ₹319.55up ₹7.85 (2.52%)BSE ₹319.60
Share price at the NSE close on 29 Oct 2026. Previous close ₹311.70.
29 Oct: open ₹320.00, high ₹325.45, low ₹311.70
52-week range of traded prices to 29 Oct 2026
₹224.10Low, 30 Mar 2026₹360.00High, 21 Sep 2026
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹1,664 Cr1,303rd largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 46.49
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 6.80
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.16%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 15.7%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 24.0%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.01
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 44,38060.4% delivered
Suraksha Diagnostic's insiders have 26 trade disclosures on record, the latest on 30 Sep 2026. Over the 12 months to 29 Oct 2026 its promoter group made 6 purchases on the market, a net purchase of 49,332 shares.
Promoter and insider buying and selling
Trades made since 30 Oct 2025.Suraksha Diagnostic promoter holding
Bought on the marketBought on the market. The value each filer stated for its purchases on the exchange, added up; gifts, transfers and pledges are not counted. A purchase filed with no value is counted under the sum, not in it. Sold on the marketSold on the market. The value each filer stated for its sales on the exchange, added up; gifts, transfers and pledges are not counted. A sale filed with no value is counted under the sum, not in it.
- Promoters and promoter group6 purchases, 0 sales₹1.39 CrNo saleNetNet. The value bought on the market less the value sold, over the trades whose filers stated a value.₹1.39 Cr1 off-market move
Bought and sold count trades on the market only. A pledge is shares given to a lender as security for a loan; a lender invokes it by selling them.
Suraksha Diagnostic insider trading
Aug 2026
- Poonam Kanodia₹0.10 Cr2,985 sharesBought · Promoter · 31 Aug 2026 · disclosed 30 Sep
Feb 2026
- Aparajita Chatterjee₹0.26 Cr9,000 sharesBought · Promoter · 25 Feb 2026 · disclosed 7 Apr
- Aparajita Chatterjee₹0.26 Cr9,000 sharesBought · Promoter Group · 25 Feb 2026 · stake 0.08% before, 0.10% after
- Aparajita Chatterjee₹0.18 Cr6,234 sharesBought · Promoter Group · 24 Feb 2026 · stake 0.07% before, 0.08% after
- Aparajita Chatterjee₹0.45 Cr15,809 sharesBought · Promoter · 23 Feb 2026 · disclosed 7 Apr
- Aparajita Chatterjee₹0.45 Cr15,809 sharesBought · Promoter Group · 23 Feb 2026 · disclosed 24 Feb · stake 0.04% before, 0.07% after
- Aparajita Chatterjee₹0.31 Cr11,044 sharesBought · Promoter Group · 20 Feb 2026 · stake 0.02% before, 0.04% after
- Aparajita Chatterjee₹0.29 Cr10,446 sharesBought · Promoter Group · 19 Feb 2026 · holds 10,446 after, stake 0.02% after
Dec 2025
- Bipul Mittal HUF₹0.04 Cr1,445 sharesBought · Promoter Group · 9 Dec 2025 · stake 0.03% before, 0.03% after
- Bipul Mittal₹0.16 Cr5,800 sharesBought · Promoter Group · 9 Dec 2025 · stake 0.03% before, 0.04% after
Sep 2025
- Ritu Mittal₹0.58 Cr19,130 sharesBought · Promoters · 29 Sep 2025 · stake 15.89% before, 15.93% after
- KISHAN KUMAR KEJRIWAL₹146 Cr48,09,062 sharesSold or invoked · Promoter · 8 Sep 2025 · disclosed 11 Sep
- Sarla Kejriwal₹146 Cr48,09,062 sharesBought · Promoter · 8 Sep 2025 · disclosed 11 Sep
Aug 2025
- Dr. Somnath Chatterjee₹0.25 Cr7,800 sharesBought · Promoters · 18 Aug 2025 · stake 5.08% before, 5.10% after
- Dr. Somnath Chatterjee₹0.25 Cr8,200 sharesBought · Promoters · 14 Aug 2025 · stake 5.07% before, 5.08% after
- Dr. Somnath Chatterjee₹0.25 Cr8,235 sharesBought · Promoters · 13 Aug 2025 · stake 5.05% before, 5.07% after
- Dr. Somnath Chatterjee₹0.25 Cr8,190 sharesBought · Promoters · 12 Aug 2025 · stake 5.03% before, 5.05% after
Jun 2025
- Dr. Somnath Chatterjee₹0.25 Cr7,450 sharesBought · Promoters · 23 Jun 2025 · disclosed 24 Jun · stake 5.02% before, 5.03% after
- Somnath Chatterjee₹0.25 Cr7,450 sharesBought · Promoter · 19 Jun 2025 · disclosed 26 Jun
- Somnath Chatterjee₹18,43456 sharesPledge · Promoter · 19 Jun 2025 · disclosed 26 Jun
- Bipul Mittal HUF₹0.50 Cr15,275 sharesBought · Promoter Group · 19 Jun 2025 · holds 15,275 after, stake 0.03% after
- Bipul Mittal₹0.50 Cr15,260 sharesBought · Promoter Group · 19 Jun 2025 · holds 15,260 after, stake 0.03% after
- Dr. Somnath Chatterjee₹0.25 Cr7,615 sharesBought · Promoters · 18 Jun 2025 · stake 5.01% before, 5.02% after
- Somnath Chatterjee₹0.25 Cr7,615 sharesBought · Promoter · 16 Jun 2025 · disclosed 20 Jun
- Somnath Chatterjee₹8,46826 sharesPledge · Promoter · 16 Jun 2025 · disclosed 20 Jun
- Dr. Somnath Chatterjee₹0.25 Cr7,590 sharesBought · Promoters · 13 Jun 2025 · stake 4.99% before, 5.01% after
Trades by the company's promoters, directors, key managers, employees and their relatives, as each disclosed them. Value is what the filer stated; the mode is shown where the shares moved off the market.
Suraksha Diagnostic stake sales and purchases
All 14 disclosures on record.
Aug 2025
- AcquiredDr. Somnath Chatterjee · promoter0.02% of the company7,800 sharesholds 5.10% after18 Aug 2025 · filed under the 2% rule · Open Market
- AcquiredDr. Somnath Chatterjee · promoter0.02% of the company8,200 sharesholds 5.08% after14 Aug 2025 · filed under the 2% rule · Open Market
- AcquiredSomnatha Chatterjee · promoter0.02% of the company8,200 sharesholds 5.08% after14 Aug 2025 · filed under the 2% rule · Open Market
- AcquiredDr. Somnath Chatterjee · promoter0.02% of the company8,235 sharesholds 5.07% after13 Aug 2025 · filed under the 2% rule · Open Market
- AcquiredDr. Somnath Chatterjee · promoter0.02% of the company8,190 sharesholds 5.05% after12 Aug 2025 · filed under the 2% rule · Open Market
Jul 2025
- AcquiredNippon Life India Trustee Limited A/c through various schemes of Nippon India Mutual Fund1.20% of the company6,27,341 sharesholds 7.48% after2 Jul 2025 · filed under the 2% rule · Open Market
- AcquiredNippon Life India trustee Limited1.20% of the company6,27,341 sharesholds 7.48% after2 Jul 2025 · filed under the 2% rule · Open Market
Jun 2025
- AcquiredDr. Somnath Chatterjee · promoter0.01% of the company7,450 sharesholds 5.03% after23 Jun 2025 · filed under the 2% rule · Open Market
- AcquiredBipul Mittal HUF · promoter0.02% of the company15,275 sharesholds 0.02% after19 Jun 2025 · filed under the 2% rule · Open Market
- AcquiredBipul Mittal · promoter0.02% of the company15,260 sharesholds 0.02% after19 Jun 2025 · filed under the 2% rule · Open Market
- AcquiredDr. Somnath Chatterjee · promoter0.01% of the company7,615 sharesholds 5.02% after18 Jun 2025 · filed under the 2% rule · Open Market
- AcquiredDr. Somnath Chatterjee · promoter0.02% of the company7,590 sharesholds 5.01% after13 Jun 2025 · filed under the 2% rule · Open Market
Jan 2025
- AcquiredKotak Mahindra Mutual Fund0.01% of the company5,733 sharesholds 5.01% after31 Jan 2025 · filed under the 5% rule · Open Market
Dec 2024
- AcquiredNippon Life India Trustee Limited5.40% of the company28,12,831 sharesholds 5.40% after5 Dec 2024 · filed under the 5% rule · Open Market
The 5% rule: an investor discloses on reaching 5% of the company. The 2% rule: a holder of 5% or more discloses each change of 2% or more, including one that takes it below 5%. A transfer exempt from an open offer, the offer to buy from every other shareholder that a large purchase otherwise brings, is disclosed too. Each line shows what its filing states, which can be a smaller change than its rule names.
Suraksha Diagnostic block deals and bulk deals
None in the last 12 months, since 30 Oct 2025.Today's bulk and block deals, all companies
ValueValue of a deal. The shares traded times the deal's price.Per cent of the companyPer cent of the company. The shares traded as a percentage of all the company's shares in issue on the day of the deal.
Tuesday 27 May 20254 firms · ₹20 Cr bought · ₹20 Cr soldNet nil
- BoughtBNP PARIBAS FINANCIAL MARKETSBlock dealBought 2,96,032 at ₹338.000.57% of the company₹10 Cr
- BoughtBNP PARIBAS FINANCIAL MARKETSBought 2,96,032 at ₹338.000.57% of the company₹10 Cr
- SoldINTEGRATED CORE STRATEGIES (ASIA) PTE. LTD.Block dealSold 2,96,032 at ₹338.000.57% of the company₹10 Cr
- SoldINTEGRATED CORE STRATEGIES (ASIA) PTE. LTD.Sold 2,96,032 at ₹338.000.57% of the company₹10 Cr
Friday 6 Dec 20241 firm · ₹16 Cr bought · ₹16 Cr soldNet sold ₹52,725
- Both waysAAKRAYA RESEARCH LLPBought 3,76,606 at ₹434.91Sold 3,76,606 at ₹435.050.72% of the companyNet nil₹16 Cr bought
A bulk deal is one client trading more than half a per cent of the shares in a day; a block deal is a large trade in the exchange's separate block window, its buyer and its seller each on a line of their own. A firm that bought and sold the shares the same day is on one line, with its net. All 4 deals on record since listing on 6 Dec 2024.